Login| Sign Up| Help| Contact|

Patent Searching and Data


Matches 551 - 600 out of 73,864

Document Document Title
WO/2016/119293A1
Provided are non-genetic recombination strains for producing N-acetyl-D-glucosamine and D-glucosamine by fermentation, the strains are preserved at China General Microbiological Culture Collection Center, one strain is Bacillus subtilis ...  
WO/2016/120549A1
The invention relates to a peptide isolate isolated from a biomass of protein-enriched microalgae. The invention is characterized in that it comprises: - soluble peptides with a molecular weight between 1 and 20 k Da, - a protein content...  
WO/2016/120405A1
The present invention refers to a composition for feeding animals comprising at least one type of microorganism of the species Lactobacillus reuteri, wherein the microorganism is species-specific for the animal fed with the composition. ...  
WO/2016/122128A1
The present invention relates to Siphoviridae bacteriophage Lac-PLP-1 (accession No. KCTC 12665BP) isolated from nature, characterized by having an ability to specifically kill Lactobacillus plantarum and the genome represented by SEQ ID...  
WO/2016/120546A1
The invention relates to a method for preparing a flour of lipid-rich microalgae, which comprises the following steps: (a) providing a biomass of microalgae comprising more than 50% lipids per dry weight of biomass; (b) lysing the microa...  
WO/2016/122127A1
The present invention relates to Siphoviridae bacteriophage Lac-BRP-1 (accession No. KCTC 12659BP) isolated from nature, characterized by having an ability to specifically kill Lactobacillus brevis and the genome represented by SEQ ID NO...  
WO/2016/119079A1
Provided are a SX-105 strain of the porcine reproductive and respiratory syndrome virus (PRRSV), the deposit number of which is CGMCC No.9906, and a use of the SX-105 strain of the porcine reproductive and respiratory syndrome virus in p...  
WO/2016/118850A1
The present invention relates to novel subspecies of Bacillus. The novel subspecies can improve health and performance of production animals. In one embodiment the Bacillus subtilis subspecies has activity against Clostridium perfringens...  
WO/2016/115903A1
Provided are a Nosema bombycis Met-AP2 gene and a use thereof in Nosema detection. Also provided are a universal Nosema detection primer pair and kit using the Met-AP2 gene as a target gene.  
WO/2016/117489A1
Provided is a culture product that contains a large amount of ethyl benzoate and has a more delicate and fresh fruit-like odor than chemically synthesized products. The culture product is obtained by culturing a microorganism belonging t...  
WO/2016/116632A1
The present invention relates to the field of microorganism strain development, more particularly to the development of heterokaryotic hybrids of the fungus species Agaricus bisporus. Even more particularly, the present invention relates...  
WO/2016/118840A1
The present invention relates to animal feed or animal feed additive comprising Bacillus strains which improve the health and performance of production animals. The invention further relates use of the Bacillus strains in animal feed and...  
WO/2016/113365A1
The present invention relates to novel Lactic Acid Bacteria strains Lactobacillus reuteri selected from the group comprising Lactobacillus reuteri DSM 32229, Lactobacillus reuteri DSM 32230, Lactobacillus reuteri DSM 32231 and Lactobacil...  
WO/2016/111368A1
The present invention addresses the problem of providing a method for producing a protein having lignin-degrading activity or a method for degrading lignin. Provided are a method for producing a protein having lignin-degrading activity a...  
WO/2016/111574A1
The present invention relates to a novel cyclic depsipeptide-based compound, a method for preparing same, and an antibacterial pharmaceutical composition containing same as an active ingredient, the novel cyclic depsipeptide-based compou...  
WO/2016/110585A1
The invention is concerned with a novel human intestinal isolate capable of converting L- lysine into butyrate and/or of converting fructose-lysine into butyrate. The novel isolate can be used as a probiotic or supplement to promote prod...  
WO/2016/107550A1
Provided is an aflatoxin-detoxifizyme mutant (ADTZ K213C/K244C/K270S) with improved trypsin resistance. The mutant is obtained by modifying a key amino acid residue at an outer layer part of a three-dimensional structure of a wild aflato...  
WO/2016/106767A1
Provided are arthrobacter ureafaciens Arthrobacter ureafaciensliulou 1 (CGMCC No. 9667) capable of degrading atrazine, and a method of using the strain for restoration from pollution caused by atrazine and/or other triazine herbicides, p...  
WO/2016/108185A1
The present invention concerns an oleaginous yeast variant of the species Rhodosporidium azoricum characterized by higher biomass yields and intra- cellular lipid accumulation useful for the production of bio-fuels higher, in determined ...  
WO/2016/108158A1
Disclosed are compositions, methods, and kits for enhanced synthesis of a biological macromolecule in vitro using cell-free protein synthesis. The compositions, methods, and kits include or utilize: a cell-free extract; a phosphate-free ...  
WO/2016/106988A1
Provided is a recombinant eukaryotic strain for producing taxadiene and a method for preparing taxadiene using same. The recombinant eukaryotic strain is obtained by introducing the following into the eukaryotic strain: a gene expression...  
WO/2016/107948A1
The present invention relates to the use of Lactobacillus rhamnosus in combination with Bifidobacterium longum to manufacture a formulation to increase male fertility in a subject. In particular, said strains are the strains Lactobacillu...  
WO/2016/108976A1
Compositions and methods include a new strain of Bacillus pumilus having plant growth promoting activity. In particular aspects, compositions containing the Bacillus pumilus strain can be applied alone or in combination with one or both ...  
WO/2016/108974A1
Compositions and methods for application to plants are provided for a new strain of Bacillus licheniformis RTI184 having plant growth promoting activity. Compositions and extracts of Bacillus licheniformis strains that include newly iden...  
WO/2016/106343A8
Aspects of the present disclosure relate to genetically engineered organisms useful for the diagnosis and treatment of inflammatory bowel disease.  
WO/2016/105483A1
Methods for increasing the genetic stability of genetically enhanced microbial host capable of producing a compound of interest are disclosed.  
WO/2016/101326A1
Provided are an oncolytic heterologous recombination Newcastle disease virus (NDV),preparation method and application thereof. The heterologous recombination NDV can express an alpha (1, 3) galactosyltransferase (alpha (1, 3) GT); the al...  
WO/2016/102853A1
The invention relates to an isolated strain of the Lactobacillus genus, characterised by its capacity to grow in the germination medium of a seed, and to limit the growth of bacteria such as Enterobactericaceae, more specifically E. coli...  
WO/2016/104437A1
A method that comprises culturing a C1 compound-assimilating bacterium and/or yeast, said bacterium and/or yeast being a methylotroph, using a medium containing a C1 compound and/or glycerol as a carbon source to thereby produce EGT.  
WO/2016/101720A1
Provided is a method for preparing Stallimycin. The method comprises: streptomycete ferments in a fermentation medium containing a carbon source, a nitrogen source and 3-hydroxy-4-amino-butyric acid, and vegetable oil is added to the fer...  
WO/2016/106343A1
Aspects of the present disclosure relate to genetically engineered organisms useful for the diagnosis and treatment of inflammatory bowel disease.  
WO/2016/095326A1
Provided is a construction method for OCH1-defective anti-CD20 tetravalent antibody expression Pichia pastoris, comprising: knocking out an OCH1 encoded α-1, 6-mannosyltransferase of a strain JC308; connecting the modified och1 with no ...  
WO/2016/097268A1
The invention relates to a genetically modified lactic acid bacterium capable of producing (S,S)-2,3-butanediol stereo specifically from glucose under aerobic conditions. Additionally the invention relates to a method for producing (S,S)...  
WO/2016/099917A1
The present invention relates in general to bacterial cells having genetic alterations that result in increased expression of a protein of interest and methods of making and using such cells. Aspects of the present invention include alte...  
WO/2016/094334A1
The invention provides a recombinant, carboxydotrophic Clostridium bacterium that expresses one or more of pyruvate:ferredoxin oxidoreductase (EC 1.2.7.1), acetolactate synthase (EC 2.2.1.6), and acetolactate decarboxylase (EC 4.1.1.5). ...  
WO/2016/092032A1
The invention relates to a probiotic strain selected from Lactobacillus reuteri V340 with accession number CECT 8605 and Bifidobacterium breve BT820 with accession number CECT 8606, or a variantof said probiotic strain having cholesterol...  
WO/2016/092201A1
The invention relates to a method for preserving microorganisms at ambient temperature, wherein: - a composition, referred to as the preservative composition, is prepared, said composition comprising the microorganisms to be preserved an...  
WO/2016/093450A1
The present invention relates to L. plantarum-K-1 BR (LP), which is lactobacillus that is separated from Kimchi and identified, the L. plantarum-K-1 BR (LP) exhibiting an anti-allergic effect; being capable of improved treatment of disea...  
WO/2016/090622A1
Provided are a hydroxyacyl-coenzyme A dehydrogenase gene and an acyl-coenzyme A thiolase gene, and a genetically-engineered bacteria and a use thereof. The hydroxyacyl-coenzyme A dehydrogenase gene encodes a protein (i) or (ii) as follow...  
WO/2016/090508A1
The invention relates to a microbiological method for the production of fluorescent, semiconductive nanoparticles (NPs) of copper sulphide, comprising the steps of: a) selecting a copper salt; b) growing a microorganism that tolerates th...  
WO/2016/090618A1
Provided are a biological metal corrosion inhibitor and a use thereof. The biological metal corrosion inhibitor contains Vibrio neocaledonicus sp., which can form a biological film with a metal corrosion inhibition effect on the surface ...  
WO/2016/090440A1
The development of attenuated live vaccines against salmonellosis has increased over the past years due to the nonexistence of completely effective vaccine formulations which enable different S. enterica serovars to be more effectively c...  
WO/2016/090556A1
Provided are a fungus-sourced high-temperature neutral Family-45 cellulase as well as a coding gene and an application thereof. The cellulase has the optimal pH value of 5.5 and the optimal temperature of 60°C, has certain enzyme activi...  
WO/2016/090343A1
Genetically engineered bacteria, pharmaceutical compositions thereof, and methods of modulating and treating disorders associated with hyperammonemia are disclosed.  
WO/2016/090343A9
Genetically engineered bacteria, pharmaceutical compositions thereof, and methods of modulating and treating disorders associated with hyperammonemia are disclosed.  
WO/2016/086554A1
Disclosed are a general monoclonal antibody for African swine fever virus strains as well as a preparation method therefor. The method comprises: immunizing a mouse by using a purified p54 immune protein, fusing spleen cells of the immun...  
WO/2016/087496A1
The present invention relates to the recombinant production of lipases in yeast. The present invention provides means and methods for improving the production of lipases in yeast.  
WO/2016/083450A3
Probiotic formulation comprising Lactobacillus plantarum TIFN 101, deposited under CBS138100, or a bacterial strain comprising a polynucleotide with at least 85% sequence identity to a polynucleotide from L.plantarum and use of the formu...  
WO/2016/085039A1
The present invention provides mixed strains for inhibiting seed germination of a weed plant consisting of Lactobacillus strains and yeast strains; a herbicide comprising the mixed strains, a culture of the strains or a concentrate of th...  
WO/2016/082305A1
Provided is a method for recombinant expression of β-glucosidase gene. Also provided is a recombinant expression vector comprising: (a) a coding sequence of an aspartic protease or active fragment thereof, (b) a coding sequence of β-gl...  

Matches 551 - 600 out of 73,864